Direct ELISA kits as a sensitive and selective screening method for abstinence control in urine

Forensic Science International

Volumn 207, Issue 1-3, 2011, Pages 66-69

  Kirschbaum, Katrin M ^a   Musshoff, Frank ^a   Wilbert, Ansgar ^a   Röhrich, Jörg ^b   Madea, Burkhard ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

Amphetamines; Cutoff value; Driving ability; ELISA; Immunoassay; Urine

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE; CANNABINOID; COCAINE; METHADONE; OPIATE;

ARTICLE; CONTROLLED STUDY; DRUG WITHDRAWAL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; URINALYSIS; URINE LEVEL;

EID: 79953063319     PISSN: 03790738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.forsciint.2010.09.002     Document Type: Article

References (14)

1. Substance Abuse and Mental Health Services Administration (SAMHSA) Mandatory Guidelines and Proposed Revisions to Mandatory Guidelines for Federal Workplace Drug Testing Programs 2009, http://www.workplace.samhsa.gov/DrugTesting/Files_Drug_Testing/Federal/HHS Mandatory Guidelines (Effective November 1, 2004).pdf (accessed 07.12.09).
2. Beurteilungskriterien: Urteilsbildung in der Medizinisch-Psychologischen Fahreignungsdiagnostik 2009, Kirschbaum Verlag, Bonn. 2nd ed. W. Schubert, R. Mattern (Eds.).
3. Society of Toxicological and Forensic Chemistry (GTFCh) Richtlinie der GTFCh zur Qualitätssicherung bei forensisch-toxikologischen Untersuchungen 2009, https://www.gtfch.org/cms/files/GTFCh_Richtlinie_For-Tox_Version 1.pdf (accessed 07.12.09).
4. Schutz H., Erdmann F., Magiera E.S., Weiler G. Analytical confirmation of error in false positive amphetamine immunoassays and results. Arch. Kriminol. 1998, 201:93-96.
5. Kupiec T., DeCicco L., Spiehler V., Sneed G., Kemp P. Choice of an ELISA assay for screening postmortem blood for amphetamine and/or methamphetamine. J. Anal. Toxicol. 2002, 26:513-518.
6. Stout P.R., Klette K.L., Wiegand R. Comparison and evaluation of DRI methamphetamine, DRI ecstasy, Abuscreen ONLINE amphetamine, and a modified Abuscreen ONLINE amphetamine screening immunoassays for the detection of amphetamine (AMP), methamphetamine (MTH), 3,4-methylenedioxyamphetamine (MDA), and 3,4-methylenedioxymethamphetamine (MDMA) in human urine. J. Anal. Toxicol. 2003, 27:265-269.
7. Savoca R., Rentsch K.M., Hubert A.R. Diagnostic efficiency of different amphetamine screening tests-the search for an optimal cutoff. Clin. Chem. Lab. Med. 2004, 42:1063-1065.
8. Apollonio L.G., Whittall I.R., Pianca D.J., Kyd J.M., Maher W.A. Matrix effect and cross-reactivity of select amphetamine-type substances, designer analogues, and putrefactive amines using the Bio-Quant direct ELISA presumptive assays for amphetamine and methamphetamine. J. Anal. Toxicol. 2007, 31:208-213.
9. Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin. Chem. 1993, 39:561-577.
10. Grauwiler S.B., Drewe J., Scholer A. Sensitivity and specificity of urinary cannabinoid detection with two immunoassays after controlled oral administration of cannabinoids to humans. Ther. Drug Monit. 2008, 30:530-535.
11. Cooper G., Wilson L., Reid C., Baldwin D., Hand C., Spiehler V. Validation of the Cozart microplate ELISA for detection of opiates in hair. J. Anal. Toxicol. 2003, 27:581-586.
12. Cooper G., Wilson L., Reid C., Hand C., Spiehler V. Validation of the Cozart Amphetamine Microplate EIA for the analysis of amphetamines in oral fluid. Forensic Sci. Int. 2006, 159:104-112.
13. Laloup M., Tilman G., Maes V., De Boeck G., Wallemacq P., Ramaekers J., Samyn N. Validation of an ELISA-based screening assay for the detection of amphetamine, MDMA and MDA in blood and oral fluid. Forensic Sci. Int. 2005, 153:29-37.
14. Spiehler V., Isenschmid D.S., Matthews P., Kemp P., Kupiec T. Performance of a microtiter plate ELISA for screening of postmortem blood for cocaine and metabolites. J. Anal. Toxicol. 2003, 27:587-591.